These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2513986)

  • 1. Survival of patients with cancer.
    Coltart S
    BMJ; 1989 Dec; 299(6712):1403. PubMed ID: 2513986
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of patients with cancer.
    Stiller CA
    BMJ; 1989 Oct; 299(6707):1058-9. PubMed ID: 2511962
    [No Abstract]   [Full Text] [Related]  

  • 3. Childhood cancer: quest for a complete cure.
    Kellie SJ; Al-Lamki Z; Agarwal BR; Wali Y; Ngcamu N; Al-Sawafi N; Kurkure P
    Pediatr Blood Cancer; 2008 Dec; 51(6):843-5. PubMed ID: 18792090
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some proposals to cancer clinical trials in Japan--a biostatistician's view].
    Oh-hashi Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2483-95. PubMed ID: 8279846
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival and Participation in a Cancer Clinical Trial: A Provocative Relationship.
    Markman M
    Oncology; 2016; 91(4):177-178. PubMed ID: 27560780
    [No Abstract]   [Full Text] [Related]  

  • 6. [Report from the colloquium on long-term clinical trial strategies].
    Sakamoto J; Nakazato H
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):701-8. PubMed ID: 2138874
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statistically significant--also relevant for the patient?].
    Lange S
    Med Klin (Munich); 1999 Apr; 94 Suppl 2():22-4. PubMed ID: 10740398
    [No Abstract]   [Full Text] [Related]  

  • 8. Teens and cancer. The care gap.
    Kiser K
    Minn Med; 2010 Oct; 93(10):7. PubMed ID: 21140754
    [No Abstract]   [Full Text] [Related]  

  • 9. [BCG-CWS as a cancer vaccine].
    Hayashi A
    Nihon Rinsho; 2002 May; 60 Suppl 5():614-20. PubMed ID: 12101748
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncology. In their prime, and dying of cancer.
    Couzin J
    Science; 2007 Aug; 317(5842):1160-2. PubMed ID: 17761859
    [No Abstract]   [Full Text] [Related]  

  • 11. [Data management for clinical trials at the data center].
    Niimi M; Fukuda H; Yamamoto S; Okuyama S; Yamaguchi N
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):253-9. PubMed ID: 9474934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ESMO 2004. Comparative studies delineating future options in the treatment of solid tumors].
    Mansueto G; Longo F
    Tumori; 2005; 91(1):suppl 21-35. PubMed ID: 15850021
    [No Abstract]   [Full Text] [Related]  

  • 13. Why event-free survival is better than tumor response or other measures of survival as an endpoint in cancer trials.
    Dillman RO
    Cancer Biother Radiopharm; 1996 Apr; 11(2):99-104. PubMed ID: 10851525
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials and survival curves: the shape of things to come.
    Elfenbein GJ
    Acta Haematol; 2001; 105(3):188-94. PubMed ID: 11463994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential for anemia treatment to improve survival in cancer patients.
    Glaspy JA
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):35-40. PubMed ID: 12380953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal for the use of progression-free survival in unblinded randomized trials.
    Freidlin B; Korn EL; Hunsberger S; Gray R; Saxman S; Zujewski JA
    J Clin Oncol; 2007 May; 25(15):2122-6. PubMed ID: 17513819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials.
    Bellera CA; Pulido M; Gourgou S; Collette L; Doussau A; Kramar A; Dabakuyo TS; Ouali M; Auperin A; Filleron T; Fortpied C; Le Tourneau C; Paoletti X; Mauer M; Mathoulin-Pélissier S; Bonnetain F
    Eur J Cancer; 2013 Mar; 49(4):769-81. PubMed ID: 23122780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalizing cancer care: American Society of Clinical Oncology presidential address 2009.
    Schilsky RL
    J Clin Oncol; 2009 Aug; 27(23):3725-30. PubMed ID: 19581526
    [No Abstract]   [Full Text] [Related]  

  • 19. Endpoints in cancer clinical trials.
    Fiteni F; Westeel V; Pivot X; Borg C; Vernerey D; Bonnetain F
    J Visc Surg; 2014 Feb; 151(1):17-22. PubMed ID: 24440056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Median follow-up in clinical trials.
    Shuster JJ
    J Clin Oncol; 1991 Jan; 9(1):191-2. PubMed ID: 1985169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.